Zhong-Tian Bai Selected Research

N-feruloyloctopamine

1/2021	N-trans-Feruloyloctopamine Wakes Up BBC3, DDIT3, CDKN1A, and NOXA Signals to Accelerate HCC Cell Apoptosis.
1/2017	Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhong-Tian Bai Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 04/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2016
1	Gastritis 04/2019
1	Carcinogenesis 02/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Chemical and Drug Induced Liver Injury 11/2015
1	Tuberculosis (Tuberculoses) 11/2015

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2018
2	N-feruloyloctopamineIBA 01/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2016
2	MicroRNAs (MicroRNA)IBA 04/2019 - 02/2018
1	Amino Acids FDA Link 01/2021
1	NeopterinIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	LipidsIBA 01/2021
1	Neuropilin-1IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 02/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2018
1	Cyclin B1IBA 01/2018
1	UbiquitinIBA 12/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 11/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 11/2015

Therapy/Procedure

1	Therapeutics 02/2018